Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

209.21
-1.4200-0.67%
Volume:230.26K
Turnover:48.37M
Market Cap:10.96B
PE:-55.52
High:211.65
Open:210.63
Low:208.01
Close:210.63
52wk High:260.19
52wk Low:112.90
Shares:52.38M
Float Shares:43.83M
Volume Ratio:0.52
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:131.55
PE(LYR):-56.82

Loading ...

May 29, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 04, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2026

Major Issues Report

Form 8-K - Current report
Feb 17, 2026

Major Issues Report

Form 8-K - Current report
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities